Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Attilio Iacovoni , Emilia D’Elia , Mauro Gori , et al Added: 3 years ago
Heart failure (HF) is a pandemic, chronic degenerative disease estimated to affect 38 million people worldwide, a number expected to increase with the ageing of the population.1 As a syndrome, it is associated with high mortality and morbidity, and consistently requires increasing resources. HF is the most frequent cause of hospitalisation in patients aged over 65 years, and hospitalised patients… View more

Heart Failure
Congestion and Diuretic Resistance in Acute or Worsening Heart Failure
Author(s): Ingibjörg Kristjánsdóttir , Tonje Thorvaldsen , Lars H Lund Added: 3 years ago
From Acute Heart Failure Towards Worsening or De Novo Heart Failure The natural history of heart failure (HF) is characterised by disease progression and episodes of worsening HF and acute decompensation requiring outpatient treatment intensification, emergency department or in-hospital care. Acute HF (AHF), also known as acute decompensated HF, is defined as a progressive and sometimes rapid… View more

Heart Failure
Role of Cardiac Troponin Levels in Acute Heart Failure
Author(s): Nicholas Wettersten , Alan S Maisel Added: 3 years ago
Cardiac troponin (cTn) is the core biomarker for the diagnosis of a myocardial infarct (MI).1 Indeed, as stated in Table 1, it meets all the definitions of a biomarker for acute coronary syndrome (ACS), as suggested by Maisel.2 In the setting of ACS, in addition to its diagnostic use, it is prognostic, clinically actionable and can be monitored during therapy as a surrogate of improvement. In… View more

Heart Failure

MI/ACS
Author(s): Maria Rosa Costanzo Added: 3 years ago
Approximately 90% of the more than 1 million yearly heart failure hospitalisations in the US and Europe are a result of symptoms and signs of fluid overload and are associated with readmission rates of 24% and 50% at 30 days and 6 months, respectively.1,2 Recurrent heart failure-related hospitalisations have uniformly been associated with worse outcomes, independent of age and renal function.3 … View more

Heart Failure
HFSA 22: HearO™ Community Study: Remote Speech Analysis of Hospitalized Pts With Acute Decompensated HF New Technology
Author(s): William T Abraham Added: 1 year ago
HFSA 2022 — Dr William T Abraham (The Ohio State University, US) talks about a study assessing a remote speech analysis application, Cordio app (Cordio Medical) that evaluated hospitalized patients with acute decompensated heart failure (NCT03266029). Questions What is the background of this study? What is the Cordio app and what is the premise behind the HearO System? What is the study design… View more

Heart Failure

Digital Health
Inotropes in Acute Heart Failure: From Guidelines to Practical Use: Therapeutic Options and Clinical Practice
Author(s): Vasiliki Bistola , Angelos Arfaras-Melainis , Eftihia Polyzogopoulou , et al Added: 3 years ago
Acute heart failure (AHF) is defined as the sudden presentation or sudden aggravation of signs and symptoms of heart failure, often requiring hospitalisation.1 It is a life-threatening condition, with in-hospital mortality ranging from 22% to 37% in severe cases of cardiogenic shock.2–4 Inotropes have been used in the management of patients with AHF for decades, especially for patients with… View more

Heart Failure
John J Atherton
Research Area(s) / Expertise: Job title: Director of Cardiology
Dr John Atherton is Director of Cardiology, Royal Brisbane and Women’s Hospital, Associate Professor, University of Queensland, and Adjunct Professor, Queensland University of Technology. Dr Atherton was on the board of the Cardiac Society of Australia and New Zealand (CSANZ, 2009–2015) and chairs the CSANZ Professional Ethics Standards Committee. He previously chaired the Asia-Pacific Acute… View more
Author(s): Ovidiu Chioncel , Sean P Collins , Stephen J Greene , et al Added: 3 years ago
Hospitalisation is a critical event in the clinical course of heart failure (HF) and despite relatively rapid relief of symptoms, hospitalisation is followed by an increased risk of death and re-hospitalisation.1 While performance measures have been developed in the last few years with the intent of improving post-discharge outcomes, post-discharge mortality rates remain unchanged or have… View more

Heart Failure
ESC 2019: Commentary on the TRANSITION-CHF and PIONEER-HF Studies
Author(s): Andrew JS Coats , Scott Solomon Added: 4 years ago
In this video Prof Scott Solomon (Harvard Medical School, MA, US) and Prof Andrew Coats (University of Warwick, UK) discuss the Systolic Dysfunction to Congestive Heart Failure Cohort Study(PROVE-HF) andAngiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure (PIONEER-HF) studies and their applicability to practice. Filmed on site at ESC 2019 by Radcliffe Cardiology. … View more

Heart Failure
Focused Ultrasound in the Emergency Department for the Diagnosis of Acute Heart Failure by Dr. Frances Russell
Author(s): Frances M Russell Start date: Jan 12, 2016

Heart Failure